Target intelligence / Profile preview

TAR RNA-binding protein 2 (TARBP2) (TARBP2)

Target
TARBP2
Molecular classification
RNA-binding protein, Double-stranded RNA-binding protein, RISC-loading complex subunit
01

Overview

TAR RNA-binding protein 2 (TARBP2), also known as TRBP, is a multi-functional double-stranded RNA-binding protein that plays a central role in the RNA interference (RNAi) pathway and viral pathogenesis [1, 5]. It is a core component of the RISC-loading complex, where it interacts with Dicer and Argonaute 2 to facilitate the processing of precursor microRNAs into mature miRNAs and their subsequent loading onto the RNA-induced silencing complex (RISC) [3, 6]. Beyond its role in RNAi, TARBP2 was originally identified for its ability to bind the HIV-1 trans-activation response (TAR) RNA element, thereby stimulating viral gene expression and replication [1, 15]. It also acts as a potent inhibitor of the interferon-induced protein kinase R (PKR), a key mediator of the innate immune response and cellular stress signaling [5, 6]. In oncology, TARBP2 exhibits a complex role, acting as either an oncogene or a tumor suppressor depending on the cancer type; for instance, it is often overexpressed in lung and breast cancers to promote growth, while mutations or downregulation are linked to colorectal and gastric cancers [4, 7, 8]. Therapeutic interest in TARBP2 focuses on modulating miRNA biogenesis or inhibiting its interaction with viral RNAs, with compounds like enoxacin demonstrating the potential to enhance its miRNA-processing activity [2, 11].

Other names
TRBPTRBP2RISC-loading complex subunit TARBP2Trans-activation-responsive RNA-binding protein
02

Mechanism of action

Enhancement of miRNA processing, inhibition of PKR activation, and modulation of RNA stability.

03

Biological functions

miRNA biogenesisRNA interferenceViral replicationPKR inhibitionTranslation regulationRNA splicingRNA stability
04

Disease associations

CancerHIV/AIDSNeurodegenerative disease
05

Safety considerations

Disruption of global miRNA biogenesisComplex role in tumorigenesis (oncogene vs tumor suppressor)Impact on innate immune signaling
06

Interacting drugs

Enoxacin

1 more in the full profile.

07

Biomarkers

TARBP2 expression levelsTARBP2 frameshift mutations

Beyond the preview

Go deeper on TAR RNA-binding protein 2 (TARBP2) (TARBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAR RNA-binding protein 2 (TARBP2) (TARBP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call